AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 47(1), 1992, pp. 1-5
Copyright © 1992 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinke, T.
Right arrow Articles by Bock, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinke, T.
Right arrow Articles by Bock, H. L.

The Efficacy of Halofantrine in the Treatment of Acute Malaria in Nonimmune Travelers

Thomas Weinke, Thomas Loscher, Klaus Fleischer, Harald Kretschmer, Hans D. Pohle, Bernd Kohler, Thomas Schlunk, Ralf Clemens AND Hans L. Bock
Universitatsklinikum Rudolf Virchow, II Medizinische Klinik, Berlin, Germany; Abteilung fur Infektions und Tropenmedizin der Universitat, Munchen, Germany; Missionsarztliche Klinik, Tropenmedizin, Wurzburg, Germany; Tropenklinik Paul-Lechler-Krankenhaus, Tubingen, Germany; Smith Kline Beecham, Klinische Forschung, Munchen, Germany

A multicenter prospective trial was performed to investigate the efficacy and the tolerability of halofantrine in nonimmune patients with malaria imported from areas with drug-resistant falciparum parasites (mainly Africa). Forty-five of the 74 subjects were treated with a one-day regimen (3 x 500 mg) of halofantrine, and the other 29 received the same regimen with an additional treatment on day 7. In the second group, a 100% efficacy rate was demonstrated, but in the group receiving the one-day regimen, four recrudescences were observed in patients with falciparum malaria. Only five mild adverse reactions were seen, which disappeared spontaneously after the end of the treatment. We conclude that halofantrine is highly effective in curing malaria in nonimmune subjects. The treatment scheme for such persons should include an additional treatment on day 7 for nonimmune individuals. This drug was well tolerated in our patients, indicating that halofantrine will be useful in the treatment of multidrug-resistant malaria in nonimmune persons.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society of Tropical Medicine and Hygiene.